FDA recall Z-0239-2022

Philips Healthcare · Class II · device

Product

DigitalDiagnost C90

Reason for recall

The Aleva monitor requires certain labels to be applied, some of which are required by FDA Electronic Product Radiation Control performance standards. This includes the Radiation Warning Label [21CFR 1020.30 (j)] and the X-ray control certification statement [21 CFR 1010.2]. Philips has determined that some systems at customer locations did not have these labels applied.

Distribution

US Nationwide Distribution

Key facts

Status
Ongoing
Initiation date
2021-09-22
Report date
2021-12-01
Voluntary/Mandated
FDA Mandated
Location
Andover, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0239-2022